BMO Capital analyst Keith Bachman reiterated a 'Market Perform' rating on UiPath (PATH) while increasing its price target from $13 to $18. This indicates a moderately positive outlook from the analyst, suggesting potential upside for the stock but not a strong buy recommendation.
BMO Capital's analyst Keith Bachman maintained a 'Market Perform' rating on UiPath, but notably raised the price target from $13 to $18. This action signals a more optimistic valuation for UiPath by BMO Capital, despite not upgrading the overall rating. For traders, this could be seen as a moderately positive signal, suggesting that the analyst sees more upside potential than previously, which might attract some buying interest in the short term. However, the 'Market Perform' rating implies that the stock is expected to perform in line with the broader market, limiting its long-term breakout potential based on this specific analysis. The key opportunity for traders lies in the potential for a short-term bump due to the increased price target.